title: Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid.
abstract: Irisin is a myokine/adipokine with potential role in obesity and diabetes. The objectives of the present study were to analyse the relationship between irisin and glucose metabolism at baseline and during an oral glucose tolerance test (OGTT) and to determine the effects of eicosapentaenoic acid (EPA) and/or α-lipoic acid treatment on irisin production in cultured human adipocytes and in vivo in healthy overweight/obese women following a weight loss program. Seventy-three overweight/obese women followed a 30% energy-restricted diet supplemented without (control) or with EPA (1.3 g/day), α-lipoic acid (0.3 g/day) or both EPA + α-lipoic acid (1.3 + 0.3 g/day) during 10 weeks. An OGTT was performed at baseline. Moreover, human adipocytes were treated with EPA (100-200 μM) or α-lipoic acid (100-250 μM) during 24 h. At baseline plasma, irisin circulating levels were positively associated with glucose levels; however, serum irisin concentrations were not affected by the increment in blood glucose or insulin during the OGTT. Treatment with α-lipoic acid (250 μM) upregulated Fndc5 messenger RNA (mRNA) and irisin secretion in cultured adipocytes. In overweight/obese women, irisin circulating levels decreased significantly after weight loss in all groups, while no additional differences were induced by EPA or α-lipoic acid supplementation. Moreover, plasma irisin levels were positively associated with higher glucose concentrations at beginning and at endpoint of the study. The data from the OGTT suggest that glucose is not a direct contributing factor of irisin release. The higher irisin levels observed in overweight/obese conditions could be a protective response of organism to early glucose impairments.
authors.affiliation: Department of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain.
authors.forename: A E
authors.initials: AE
authors.lastname: Huerta
authors.forename: P L
authors.initials: PL
authors.lastname: Prieto-Hontoria
authors.forename: M
authors.initials: M
authors.lastname: Fernández-Galilea
authors.forename: N
authors.initials: N
authors.lastname: Sáinz
authors.forename: M
authors.initials: M
authors.lastname: Cuervo
authors.forename: J A
authors.initials: JA
authors.lastname: Martínez
authors.forename: M J
authors.initials: MJ
authors.lastname: Moreno-Aliaga
mesh_terms: D052438:Adipocytes, White / Q000187:drug effects / Q000378:metabolism; D000328:Adult; D001786:Blood Glucose; D031204:Caloric Restriction; D002478:Cells, Cultured; D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage*; D005260:Female; D005353:Fibronectins / Q000097:blood*; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000097:blood* / Q000178:diet therapy; D050151:Subcutaneous Fat / Q000473:pathology; D008063:Thioctic Acid / Q000008:administration & dosage*; D016896:Treatment Outcome; D015431:Weight Loss; D055815:Young Adult
chemical_list: D001786:Blood Glucose; C577593:FNDC5 protein, human; D005353:Fibronectins; D008063:Thioctic Acid; D015118:Eicosapentaenoic Acid; D005947:Glucose
references.citation: PLoS One. 2013 Apr 11;8(4):e60563
references.pmid: 23593248
references.citation: Clin Endocrinol (Oxf). 2014 Aug;81(2):306-11
references.pmid: 24325584
references.citation: J Diabetes Complications. 2013 Jul-Aug;27(4):365-9
references.pmid: 23619195
references.citation: Obesity (Silver Spring). 2014 Oct;22(10):2210-5
references.pmid: 25045030
references.citation: Am J Med. 2011 Jan;124(1):85.e1-8
references.pmid: 21187189
references.citation: Eur J Clin Invest. 2014 Oct;44(10):918-25
references.pmid: 25112714
references.citation: Mol Nutr Food Res. 2013 Aug;57(8):1456-67
references.pmid: 23650203
references.citation: J Physiol Biochem. 2009 Mar;65(1):43-50
references.pmid: 19588730
references.citation: J Physiol. 2014 Mar 1;592(5):1091-107
references.pmid: 24297848
references.citation: Metabolism. 2010 Jul;59(7):967-76
references.pmid: 20015518
references.citation: Acta Physiol (Oxf). 2015 Mar;213(3):711-21
references.pmid: 25382002
references.citation: Mol Nutr Food Res. 2011 Jul;55(7):1059-69
references.pmid: 21351249
references.citation: Obesity (Silver Spring). 2015 Feb;23(2):313-21
references.pmid: 25594166
references.citation: FEBS J. 2014 Feb;281(3):739-49
references.pmid: 24237962
references.citation: J Physiol Biochem. 2011 Sep;67(3):479-86
references.pmid: 21461750
references.citation: Int J Cardiol. 2013 Jul 31;167(2):602-3
references.pmid: 23102606
references.citation: J Physiol Biochem. 2013 Sep;69(3):633-51
references.pmid: 23794360
references.citation: Acta Diabetol. 2014 Oct;51(5):705-13
references.pmid: 24619655
references.citation: Br J Nutr. 2009 Apr;101(7):1059-67
references.pmid: 18755047
references.citation: Curr Pharm Des. 2010;16(7):840-6
references.pmid: 20388095
references.citation: Br J Nutr. 2007 Feb;97(2):389-98
references.pmid: 17298710
references.citation: Metabolism. 2012 Dec;61(12):1725-38
references.pmid: 23018146
references.citation: J Hepatol. 2013 Sep;59(3):557-62
references.pmid: 23665283
references.citation: Peptides. 2013 Jan;39:125-30
references.pmid: 23219488
references.citation: PLoS One. 2014 Apr 07;9(4):e94235
references.pmid: 24709991
references.citation: Nutr Diabetes. 2014 Feb 24;4:e110
references.pmid: 24567125
references.citation: Biochem Biophys Res Commun. 2000 Apr 13;270(2):343-8
references.pmid: 10753628
references.citation: Nature. 2012 Jan 11;481(7382):463-8
references.pmid: 22237023
references.citation: J Clin Endocrinol Metab. 2013 Apr;98(4):E769-78
references.pmid: 23436919
references.citation: Int J Endocrinol. 2014;2014:857270
references.pmid: 24864142
references.citation: Proc Nutr Soc. 2010 Aug;69(3):324-32
references.pmid: 20540825
references.citation: Circulation. 2002 Oct 15;106(16):2067-72
references.pmid: 12379575
references.citation: Metab Syndr Relat Disord. 2008 Dec;6(4):299-304
references.pmid: 19067533
references.citation: FASEB J. 2013 May;27(5):1981-9
references.pmid: 23362117
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1682-8
references.pmid: 15650121
references.citation: Obesity (Silver Spring). 2008 Sep;16(9):2046-52
references.pmid: 19186329
references.citation: Eur J Nutr. 2013 Mar;52(2):779-87
references.pmid: 22664981
references.citation: Diabetes Res Clin Pract. 2013 Apr;100(1):96-101
references.pmid: 23369227
references.citation: Altern Med Rev. 2007 Dec;12(4):343-51
references.pmid: 18069903